5-MeO-DALT Powder
€ 65,00 – € 250,00Price range: € 65,00 through € 250,00
5-MeO-DALT is described as a substituted tryptamine research material associated with N,N-diallyl-5-methoxytryptamine.
The named compound belongs to the 5-methoxytryptamine family and contains an indole framework with a methoxy substituent and an aminoethyl side chain bearing two allyl groups on the nitrogen atom.
The supplied source presents the material as a powder intended for controlled analytical and laboratory research.
Its stated scientific context includes chemical identification, compound characterization, analytical method development, and reference-oriented investigation of substituted tryptamines.
However, the exact chemical form, physical characteristics, ingredient purity, and batch-specific analytical identity have not been independently established.
The source refers to Certificates of Analysis, batch tracking, and laboratory verification where applicable. No actual supporting documentation accompanied these statements.
The material is not established as a certified reference material or validated quantitative calibration standard.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
5-MeO-DALT Powder – N,N-Diallyl-5-Methoxytryptamine Research Material
Product Overview
5-MeO-DALT Powder refers to a material described as containing N,N-diallyl-5-methoxytryptamine, commonly abbreviated 5-MeO-DALT.
The named compound belongs to the substituted tryptamine family and is classified as a 5-methoxytryptamine derivative.
Its proposed molecular framework contains a methoxy-substituted indole ring and an aminoethyl side chain bearing two allyl substituents on the nitrogen atom.
This structural arrangement distinguishes 5-MeO-DALT from tryptamine derivatives containing different nitrogen substituents or indole-ring modifications.
The supplied source presents the material as a laboratory research preparation associated with analytical identification and scientific documentation.
Its stated research context includes chemical characterization, analytical method development, and reference-oriented investigation.
These references describe potential laboratory research topics rather than independently verified performance characteristics of the actual product.
The source identifies the material as a powder and describes quality-assurance practices intended to support research documentation.
However, no actual batch-specific analytical report, independent identity certificate, or product inspection record accompanied the information.
The stated product characteristics therefore remain source-provided specifications.
5-MeO-DALT is not established here as a certified reference material, validated quantitative calibrator, or approved pharmaceutical preparation.
Chemical Identity & Classification
The supplied source identifies 5-MeO-DALT as N,N-diallyl-5-methoxytryptamine, a substituted tryptamine.
Its chemical classification places it within the 5-methoxytryptamine family of indolealkylamines.
The supplied product information includes:
- Common designation: 5-MeO-DALT
- Chemical name: N,N-Diallyl-5-methoxytryptamine
- Chemical classification: Substituted tryptamine; 5-methoxytryptamine derivative
- Reported presentation: Powder
- Intended designation: Research Use Only
The source does not provide a CAS Registry Number, molecular formula, molecular weight, complete systematic chemical name, or confirmed salt form.
These details should not be inferred from the product title alone.
The exact chemical form of the ingredient is relevant to interpreting molecular-weight calculations and analytical measurements.
The source does not establish whether the actual powder contains the free base or a specific salt.
No verified structural analysis or batch-specific identity report was supplied.
Researchers may consult PubChem for public chemical-reference information, while ensuring that any selected record corresponds to the actual chemical form being examined.
Chemical & Physical Characteristics
The supplied source describes the product as a powder.
No actual product-specific inspection report, particle-size measurement, melting-point determination, or quantitative solubility profile was provided.
The physical presentation therefore remains a source-provided description.
The named compound contains a methoxy substituent at the 5-position of the indole framework.
Its side-chain nitrogen is described as bearing two allyl substituents.
These structural features distinguish 5-MeO-DALT from other substituted tryptamines with different ring or nitrogen substitution patterns.
However, structural classification alone does not establish the physicochemical characteristics of the actual material.
The source does not provide experimentally verified melting-point data, solubility measurements, degradation profiles, or complete physical characterization.
The exact salt form, if any, is not identified.
The source recommends cool, dry storage protected from light and moisture.
No validated product-specific stability study or established shelf-life specification accompanied that recommendation.
The supplied information therefore does not support definitive statements concerning storage-dependent degradation rates or long-term chemical stability.
Purity & Analytical Verification
The supplied source states that batch-specific purity information may be available through a Certificate of Analysis.
However, it does not provide a numerical purity specification or an actual analytical report.
No batch-specific chromatogram, mass spectrum, NMR spectrum, or independent laboratory certificate accompanied the information.
Accordingly, no particular purity threshold can be presented as independently verified.
The source identifies analytical and reference-oriented research as the intended laboratory context.
Chemical characterization may involve examination of molecular identity, structural features, impurity profiles, and analytical specificity.
However, naming a research context does not establish that the actual product has undergone a particular analytical test.
The source also describes the material as suitable for reference-oriented research.
That description does not establish certified reference-material status or validated quantitative calibration performance.
No assigned measurement values, uncertainty statements, metrological traceability records, or independently verified analytical specifications were supplied.
Any definitive product-specific analytical claims should be supported by actual batch documentation.
Quality Control & Batch Integrity
The supplied source refers to Certificates of Analysis, lot tracking, and laboratory verification where applicable.
These statements describe proposed or claimed quality-assurance practices.
No actual certificate, independent testing report, manufacturing audit, laboratory accreditation record, or batch-specific quality-control document accompanied the information.
They therefore remain unverified supplier statements.
For reproducible scientific documentation, relevant records may include verified chemical identifiers, batch number, analytical findings, receipt date, and available storage history.
The chemical form of the active ingredient should also be documented.
The supplied information does not establish independently verified purity, chemical form, or batch consistency.
The existence of a Research Use Only designation does not itself demonstrate manufacturing quality or analytical traceability.
Claims of consistent purity, identity, and manufacturing quality should be supported by actual records rather than inferred from general quality-assurance language.
Safety, Handling & Laboratory Precautions
5-MeO-DALT is a synthetic substituted tryptamine associated with potentially significant toxicological uncertainties.
The supplied source does not provide a complete product-specific toxicological assessment.
Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.
Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.
The powder presentation does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual chemical form, purity, and physical characteristics have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes protective packaging, controlled handling, and professional shipment arrangements.
No actual packaging specification, container-validation report, or shipment-condition record was provided.
The source recommends sealed storage in a cool, dry environment protected from light and moisture.
No validated product-specific stability data was provided to establish a particular storage temperature or shelf life.
Laboratory inventory records should preserve the product designation, chemical form if confirmed, any available batch identifier, receipt details, and relevant storage observations.
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.
The source’s general handling recommendations should not be interpreted as evidence of validated long-term stability.
Intended Research Use & Market Positioning
The supplied scientific context places 5-MeO-DALT within analytical research involving substituted tryptamines, 5-methoxytryptamine derivatives, and chemical identification.
Its proposed N,N-diallyl substitution pattern provides a basis for comparative examination of related molecular structures.
The source describes the material as intended for controlled laboratory settings and reference-oriented scientific workflows.
These statements identify a research context but do not establish certified reference-material status or validated performance for the actual powder.
The supplied Raw Lab Chems catalog includes 5-MeO-DALT , corresponding to the listing discussed here.
For comparative chemical-catalog context, Raw Lab Chems also lists 5-MeO-MiPT Pellets and NB-5-MeO-DALT Oxalate Powder.
5-MeO-MiPT is a differently substituted tryptamine and should not be treated as chemically identical or analytically interchangeable with 5-MeO-DALT.
The NB-5-MeO-DALT Oxalate listing refers to a separately designated derivative and salt preparation. Its identity and chemical form should not be assumed to match the present material.
The supplied information does not establish equivalent chemical forms, ingredient purity, or analytical characteristics across these listings.
These references provide catalog context rather than evidence of certified reference-material status or product equivalence.
Ordering, Availability & Fulfillment
The supplied source describes protective packaging and international shipping arrangements.
No current inventory record, shipment authorization, carrier documentation, or verified delivery information was supplied.
Consequently, no availability, delivery, customs-clearance, or transportation-compliance guarantee is asserted.
5-MeO-DALT and related substituted tryptamines may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.
Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.
Research-only labeling does not establish a legal exemption.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
5-MeO-DALT is a synthetic substituted tryptamine whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.
The supplied information does not establish universal legal status or regulatory authorization.
Institutions remain responsible for determining the applicable legal requirements and obtaining any necessary permissions.
No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.
| Quantity (0.5 grams) |
2 ,5 ,10 |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.